🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Steven D Wexner MD, PhD Dana Sands Roel Hompes Antonino Spinelli andre dhoore Annals of Surgery Noticed and 👏, addressed in the discussion with some possible explanation. Nevertheless, after 🇳🇴+🇳🇱alarm on #TaTME not coming from tertiary referral centers, more external audits and robust trial data needed. Quick📸 series from expert centers👉excellent! #colorectalsurgery

The learning curve of TaTME for #rectalcancer is associated with local recurrence >12% during the learning curve ⬇️ to > 3% with experience Jurriaan Tuynman Stefan v Oostendorp Sietses EAES European Society of Coloproctology Werkgroep Coloproctologie Nederland #openaccess Colorectal Disease onlinelibrary.wiley.com/share/RIDUERAC…

Looking forward!

Congratulations Dr. F. Borja de Lacy, MD, PhD on your incredibly impressive defense today of your PhD thesis Universitat de Barcelona and the very well deserved unanimous recommendation of the tribunal of your being awarded with your well earned PhD degree Jose M. Balibrea MD, PhD, FACS Antonio de Lacy AIS Channel

Last Friday 2/7/‘21 - #PhD defense Amsterdam UMC Vrije Universiteit Amsterdam (inactief) “Minimally invasive treatment strategies for rectal cancer” Thank to my supervisors, coauthors and collaborators over the world #SoMe4Surgery #TaTME #TAMIS #colorectalsurgery @CRS_trials COLOR III Werkgroep Coloproctologie Nederland SoMe4Surgery

Today the virtual 16th Annual Scientific Conference of the European Society of Colorproctology European Society of Coloproctology starts. On Friday Sept 24th we will present the COLOR III trial at the 'New Trial Forum' (time: 8.30AM till 09.45AM) to invite even more centers to join the COLOR3 group!

Today we will be presenting the COLOR III trial at the ESCP conference! #ESCP2021 Please join us! #tatme #rectum

📈Study update #TaTME: #649 randomized pts of the full sample size of #1104! Top 3 including centers: 1. Beijing Friendship Hospital China 蔡清华, 2. Gelderse Vallei NL Sietses and Shanghai Renji Hospital China qing xu. Big🙏to all collaborators for their great work

🚨Accrual update 26 nov '21 Total patients registered 747 Randomized 680 Some excl by second read of MRI /M+ 👏Participating centres 🙏 for efforts so far, please keep including patients! #TaTME EAES #WCES2021 Antonio de Lacy Sietses Felix Aigner Stefan v Oostendorp

Steven D Wexner MD, PhD Paris Tekkis Journal of the @NCCN taTME SURGERY TaTME Education @TATMEtrainingUK UStaTMEtrial Patricia Sylla Sam Atallah, MD Matthew Albert TAMIS SURGERY Antonio Caycedo-Marulanda MD, MSc. Sami A. Chadi MD Thank you Steven D Wexner MD, PhD for the excellent editorial. More data to come from UStaTMEtrial COLOR III hopefully soon in support of safe taTME SURGERY. Thanks to all collaborative surgeons who contribute to TaTME registry

In November's issue of BJS: Comparison of laparoscopic versus robot-assisted versus transanal total mesorectal excision surgery for rectal cancer academic.oup.com/bjs/article/10… Amy Lee Lightner, MD Bas Wijnhoven Des Winter Kjetil Søreide Malin Sund Martyn Evans Niels Kok Robert Hinchliffe Young BJS

📈Trial update 6.1.22 We have reached #700! Total registered 773, randomized 705. Top including centers of Dec = Friendship Hospital Beijing (8), Gelderse Vallei (3), NCCH-East Japan (3), FHA-Chongqing (3).The accrual of Dec = 23. Big🙏to all! #tatme Sietses Antonio de Lacy

Looking for to the 3rd PelvEx meeting in the beautiful city Amsterdam - See PelvEx2022.org for details ⁦PelvEx⁩ ⁦Jurriaan Tuynman⁩ @ P Burger, J Tolenaar and A Aalbers ⁦Des Winter⁩ ⁦Michael Kelly⁩ ⁦European Society of Coloproctology⁩ ⁦ASCRS_1⁩

Please join us at the international COLOR III meeting on the 3rd of March 2022 at 13:00hr (Amsterdam Time) with our collaborators from all over the world! We will discuss the progress of the COLOR III trial and interesting topics regarding rectal surgery #TaTME #rectalsurgery

“Surgeons with experience in TaTME are not advised against performing TaTME in patients with low rectal cancer …”. link.springer.com/article/10.100…

🏆Today our top 1 including center Friendship Hospital Beijing included their 100th COLOR patient! Congratulations and thank you for your fantastic work! Special thanks to @Hongweiyao #TaTME #rectalsurgery #color3china

📈 Trial update: we have included 857 patients and randomized 786 patients! Top including centers are Beijing Friendship Hospital (China), National Cancer Center Hospital East (Japan) and Gelderse Vallei (Netherlands). A big thanks to all participating centers! #tatme #surgery

COLOR3 update📢: currently we have included 952 and randomized 874 patients! Thanks to all centers and their persistant effort in this high quality trial on #tatme and #laptme! Please keep on including patients to reach the full sample size of 1104 patients next year. 🙏

COLOR trial update: we have reached 900 randomized patients! Thanks to all centers for their hard work, we had a very fruitful year and are close to the full sample size of 1104 patients. Lets finish in 2023! #tatme #rectalsurgery

Exciting news! The COLOR3 trial has just reached a major milestone. We have successfully randomised 1000 patients! We would like to thank all participating centres for their great efforts. We hope to reach final enrolment in December or January 2024! Let's keep up the good work!